Observatory · observe first
Follow the allocation change
Matched S&P 500 members → sector → industry → sub-industry → company. Each step uses the same percentage points.
Historical time machine
Historical observation
20182026
1 · Sector
Weight and 12M allocation change
2 · Industry
Inside Health Care
Pharmaceuticals4.61%+4.60 ppHealth Care Equipment3.14%+3.13 ppManaged Health Care2.10%+2.10 ppBiotechnology2.08%+2.07 ppLife Sciences Tools & Services2.00%+2.00 ppHealth Care Services0.92%+0.91 ppHealth Care Distributors0.29%+0.29 ppHealth Care Supplies0.28%+0.28 ppHealth Care Facilities0.25%+0.25 ppHealth Care Technology0.00%+0.00 pp
3 · Sub-industry
Inside Biotechnology
Biotechnology · weight
2.08%
Industry change · 12M
+2.07 pp
Biotechnology · contribution
+2.073 pp
Company participation
100%
of industry constituents above their 6M weight average
4 · Companies driving this sub-industry
May 2021 · sorted by absolute contribution to 12-month change
| Company | Country | Market cap | Universe weight | 3M contribution | 12M contribution | 12M price return | Above 6M weight average |
|---|---|---|---|---|---|---|---|
| AbbVie → ABBV | United States | $199.9bn | 0.716% | +0.336 pp | +0.715 pp | +28.3% | Yes |
| Amgen → AMGN | United States | $136.7bn | 0.490% | +0.230 pp | +0.489 pp | +6.5% | Yes |
| Gilead Sciences → GILD | United States | $82.9bn | 0.297% | +0.143 pp | +0.296 pp | -11.4% | Yes |
| Vertex Pharmaceuticals → VRTX | United States | $54.0bn | 0.193% | +0.083 pp | +0.193 pp | -27.5% | Yes |
| Regeneron Pharmaceuticals → REGN | United States | $47.2bn | 0.169% | +0.085 pp | +0.169 pp | -18.0% | Yes |
| Biogen → BIIB | United States | $40.3bn | 0.144% | +0.061 pp | +0.144 pp | -12.9% | Yes |
| Incyte → INCY | United States | $18.4bn | 0.066% | +0.031 pp | +0.066 pp | -17.8% | Yes |
Company contributions use weights among matched S&P 500 members and add through each level without rescaling. Companies without matched shares and prices are omitted. These observations do not establish official index weights or actual fund flows.